Dental Prosthesis, Implant-Supported
Conditions
Interventions
The study will be controlled clinical, double blind with follow-up of 18 months. 90 patients will be selected, with indication to perform 1 or 2 implants in the premolars or upper or lower molars regi
E07.695.340
Sponsors
Universidade Federal do Rio de Janeiro
Instituto de Ciência e Tecnologia de São José dos Campos
Eligibility
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients between 18 and 70 years of age, of both sexes; Patients who are missing 1, up to 2 molars and/or premolars with an indication of receiving osseointegrated implants;The opposing tooth must be sound or with a small restoration (occlusal isthmus of a maximum occlusal 1/3); There must be the presence of collateral teeth to the implant without proximal restorations; Signing of the Free and Informed Consent Term (TCLE) for participating in the research, after explaining the risks and benefits (Resolution No. 196 of October 1996 and the Dental Professional Code of Ethics – C.F.O. - 179/93)
Exclusion criteria
Exclusion criteria: Severe periodontal disease, caries disease and poor oral hygiene; Patient without antagonist tooth or with removable prostheses; Patient with the opposing tooth to the restored implant; Missing posterior tooth; Patient with comorbidities that contraindicate implant surgery; Pregnant and lactating patients; Patients who make continuous use of corticoid anti-inflammatory drugs; Antibiotic therapy in the last 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate how experimental glass infiltration in Implanted Crowns of 5Y-PSZ zirconia affects color stability through the color evaluation method through Vita Easy Shade®.;Evaluate how experimental glass infiltration in Implanted Crowns of 5Y-PSZ zirconia affects both glass and antagonist tooth wear through the scanning and overlapping method.;Evaluate how experimental glass infiltration in Implanted Crowns of 5Y-PSZ zirconia affects the periimplant and immune clinical prognosis through the method of clinical and immunological evaluations. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary completions are not expected. | — |
Countries
Brazil
Contacts
Public ContactAmanda Ribeiro
Universidade Federal do Rio de Janeiro
Outcome results
None listed